Burns J W & Co. Inc. NY Has $1.57 Million Position in The Clorox Company (NYSE:CLX)

Burns J W & Co. Inc. NY lowered its position in shares of The Clorox Company (NYSE:CLX) by 0.8% in the first quarter, according to its most recent disclosure with the SEC. The institutional investor owned 10,226 shares of the company’s stock after selling 83 shares during the quarter. Burns J W & Co. Inc. NY’s holdings in Clorox were worth $1,566,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. CIBC Private Wealth Group LLC lifted its position in shares of Clorox by 0.5% during the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock valued at $1,982,000 after acquiring an additional 66 shares during the period. First National Bank of Mount Dora Trust Investment Services raised its holdings in Clorox by 3.2% in the 4th quarter. First National Bank of Mount Dora Trust Investment Services now owns 2,257 shares of the company’s stock valued at $322,000 after buying an additional 71 shares during the last quarter. Modera Wealth Management LLC boosted its position in Clorox by 1.4% during the 3rd quarter. Modera Wealth Management LLC now owns 5,130 shares of the company’s stock worth $672,000 after buying an additional 71 shares during the period. Czech National Bank grew its holdings in Clorox by 0.3% during the 4th quarter. Czech National Bank now owns 21,718 shares of the company’s stock worth $3,097,000 after acquiring an additional 71 shares during the last quarter. Finally, Global Retirement Partners LLC increased its position in Clorox by 7.2% in the 4th quarter. Global Retirement Partners LLC now owns 1,089 shares of the company’s stock valued at $156,000 after acquiring an additional 73 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Stock Down 0.1 %

CLX stock traded down $0.13 during midday trading on Friday, reaching $136.47. 1,667,373 shares of the company’s stock traded hands, compared to its average volume of 1,254,727. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $169.14. The company has a market cap of $16.95 billion, a price-to-earnings ratio of 70.72, a P/E/G ratio of 2.19 and a beta of 0.39. The firm’s fifty day moving average price is $136.95 and its 200-day moving average price is $143.79. The company has a quick ratio of 0.53, a current ratio of 0.90 and a debt-to-equity ratio of 9.73.

Clorox (NYSE:CLX) last released its earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The company had revenue of $1.81 billion during the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a return on equity of 302.49% and a net margin of 3.33%. The firm’s revenue for the quarter was down 5.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.51 EPS. As a group, sell-side analysts forecast that The Clorox Company will post 5.91 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. Morgan Stanley restated an “equal weight” rating and issued a $160.00 price objective on shares of Clorox in a report on Tuesday, March 26th. Evercore ISI lowered their price objective on Clorox from $145.00 to $142.00 and set an “underperform” rating for the company in a research report on Wednesday, May 1st. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 target price on the stock in a report on Tuesday, March 26th. Barclays lowered their price target on shares of Clorox from $136.00 to $132.00 and set an “underweight” rating for the company in a report on Thursday, May 2nd. Finally, DA Davidson reaffirmed a “neutral” rating and issued a $162.00 price objective on shares of Clorox in a research note on Wednesday, April 17th. Five equities research analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $145.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.